Literature DB >> 32783759

What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?

Fernando Elijovich1, Cheryl L Laffer1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32783759     DOI: 10.1161/HYPERTENSIONAHA.120.15712

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  3 in total

1.  Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.

Authors:  Renato D Lopes; Ariane V S Macedo; Pedro G M de Barros E Silva; Renata J Moll-Bernardes; Tiago M Dos Santos; Lilian Mazza; André Feldman; Guilherme D'Andréa Saba Arruda; Denílson C de Albuquerque; Angelina S Camiletti; Andréa S de Sousa; Thiago C de Paula; Karla G D Giusti; Rafael A M Domiciano; Márcia M Noya-Rabelo; Alan M Hamilton; Vitor A Loures; Rodrigo M Dionísio; Thyago A B Furquim; Fábio A De Luca; Ítalo B Dos Santos Sousa; Bruno S Bandeira; Cleverson N Zukowski; Ricardo G G de Oliveira; Noara B Ribeiro; Jeffer L de Moraes; João L F Petriz; Adriana M Pimentel; Jacqueline S Miranda; Bárbara E de Jesus Abufaiad; C Michael Gibson; Christopher B Granger; John H Alexander; Olga F de Souza
Journal:  JAMA       Date:  2021-01-19       Impact factor: 56.272

2.  New Insights Into the Renin-Angiotensin System in Chronic Kidney Disease.

Authors:  Cheryl L Laffer; Fernando Elijovich; Melis Sahinoz; Ashley Pitzer; Annet Kirabo
Journal:  Circ Res       Date:  2020-08-13       Impact factor: 17.367

3.  Hypertension Update: A Reflection of the Past Decade.

Authors:  Anna F Dominiczak; Trudie J Meyer
Journal:  Hypertension       Date:  2021-11-10       Impact factor: 10.190

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.